Interaction of inhalational anaesthetics with CO2 absorbents

Best Practice and Research: Clinical Anaesthesiology

Volumn 17, Issue 1, 2003, Pages 63-76

  Baum, Jan A ^a,b   Woehlck, Harvey J ^c  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Hospital St Elisabeth Stift   (Germany)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Calcium hydroxide lime; Carbon dioxide absorbents; Carbon monoxide; Compound A; Degradation; Inhalation anaesthetics; Lithium hydroxide; Non caustic lime; Soda lime

Indexed keywords

2,2 DIFLUORO 1 (TRIFLUOROMETHYL)VINYL FLUOROMETHYL ETHER; ABSORBENT; BARIUM DERIVATIVE; CALCIUM HYDROXIDE; CALCIUM OXIDE; CARBON DIOXIDE; CARBON MONOXIDE; DESFLURANE; ENFLURANE; ETHYLENE DERIVATIVE; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; LITHIUM DERIVATIVE; POTASSIUM HYDROXIDE; SEVOFLURANE; SODIUM HYDROXIDE; BARA LIME; CALCIUM DERIVATIVE; DRUG DERIVATIVE; ETHER DERIVATIVE; OXIDE; POTASSIUM DERIVATIVE; SODA LIME;

ANESTHETIC EQUIPMENT; BREATHING APPARATUS; CARBON MONOXIDE INTOXICATION; CHEMICAL INTERACTION; CHEMICAL REACTION; CLINICAL TRIAL; DESICCATION; DRUG DEGRADATION; FLOW RATE; GAS FLOW; HUMAN; KIDNEY DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SURGICAL PATIENT; ABSORPTION; ARTICLE; CHEMISTRY;

ABSORPTION; ANESTHETICS, INHALATION; BARIUM COMPOUNDS; CALCIUM COMPOUNDS; CALCIUM HYDROXIDE; CARBON DIOXIDE; ISOFLURANE; METHYL ETHERS; OXIDES; POTASSIUM COMPOUNDS; SODIUM HYDROXIDE;

EID: 0038387345     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1053/bean.2003.0269     Document Type: Article

References (68)

1. Baum J Development of rebreathing systems Low Flow Anaesthesia 2001 Butterworth Heinemann Oxford 21-32
2. Strum D P Eger E I II The degradation, absorption, and solubility of volatile anesthetics in soda lime depend on water content Anesthesia and Analgesia 78 1994 340-348
3. Fang Z X Eger E I II Laster M J et al. Carbon monoxide production from degradation of desflurane, enflurane isoflurane, halothane and sevoflurane by soda lime and Baralyme Anesthesia and Analgesia 80 1995 1187-1193
4. Baum J Sachs G von der Driesch C Carbon monoxide generation in carbon dioxide absorbents Anesthesia and Analgesia 81 1995 144-146
5. Berry P D Sessler D I Larson M D Severe carbon monoxide poisoning during desflurane anesthesia Anesthesiology 90 1999 613-616
6. Pankow D Toxikologie des Kohlenmonoxids 1981 VEB Verlag Volk und Gesundheit Berlin 55-56
7. 2 inhalation. A method for the rapid elimination of carbon monoxide from the blood Journal of the American Medical Association 79 1922 1137
8. Middleton V van Poznak A Artusio JF et al. Carbon monoxide accumulation in closed circle anesthesia systems Anesthesiology 26 1965 715-719
9. Strauß JM Baum J Sümpelmann R Zersetzung von Halothan, Enfluran und Isofluran an trockenem Atemkalk zu Kohlenmonoxid Anaesthesist 45 1996 798-801
10. Wissing H Kuhn I Warnken U Carbon monoxide production from desflurane, enflurane, halothane, isoflurane, and sevoflurane with dry soda lime Anesthesiology 95 2001 1205-1212
11. Funk W Gruber M Wild K Dry soda lime markedly degrades sevoflurane during simulated inhalation induction British Journal of Anaesthesia 82 1999 193-198
12. 2 absorbents Anesthesiology 95 2001 A1190
13. Baum J Sitte Th Strauß JM Die Reaktion von Sevofluran mit trockenem Atemkalk - Überlegungen zu einem aktuellen Zwischenfall Anästhesiologie - Intensivmedizin 39 1998 11-16
14. Holak E J, Mei D A, Dunning III M B, et al., Carbon monoxide production from sevoflurane breakdown: Modeling of exposures under clinical conditions, Anesthesia and Analgesia (in press)
15. Woehlck HJ Dunning M III Connolly L A Reduction in the incidence of carbon monoxide exposures in humans undergoing general anaesthesia Anesthesiology 87 1997 228-234
16. Baum J Atemkalk: Hinweise zu korrektem Umgang und fachgerechter Nutzung. Stellungnahme der Kommission für Normung und technische Sicherheit der DGAI Anästhesiologie - Intensivmedizin 40 1999 507-509
17. Kharasch ED Powers KM Artu AA Comparison of Amsorb, Sodalime and Baralyme degradation of volatile anesthetics and formation of carbon monoxide and compound A in swine in vivo Anesthesiology 96 2002 173-182
18. Sharp HJ Trudell JR Cohen EN Volatile metabolites and decomposition products of halothane in man Anesthesiology 50 1979 2-8
19. Kenna JG Jones RM The organ toxicity of inhalaed anesthetics Anesthesia and Analgesia 81 1995 S51-S66
20. Fang Z X Eger EI II Factors affecting the concentration of compound A resulting from degradation of sevoflurane by soda lime and Baralyme in a standard anesthetic circuit Anesthesia and Analgesia 81 1995 564-568
21. Fang ZX Kandel L Laster MJ et al. Factors affecting production of compound A from the interaction of sevoflurane with Baralyme and soda lime Anesthesia and Analgesia 82 1996 775-781
22. Bito H Ikeda K Effect of total flow rate on the concentration of degradation products generated by the reaction between sevoflurane and soda lime British Journal of Anaesthesia 74 1995 667-669
23. Bito H Ikeda K Long-duration, low-flow sevoflurane anesthesia using two carbon dioxide absorbents Anesthesiology 81 1994 340-345
24. Morio M Fujii K Satoh N et al. Reaction of sevoflurane and its degradation products with soda lime. Toxicity of the byproducts Anesthesiology 77 1992 1155-1164
25. Smith I Nathanson M White PF Sevoflurane - a long-awaited volatile anaesthetic British Journal of Anaesthesia 76 1996 435-445
26. Gonsowski CT Laster MJ Eger EI II et al.Toxicity of compound A in rats. Effect of a 3-hour administration Anesthesiology 80 1994 556-565
27. Keller KA Callan C Prokocimer P et al. Inhalation toxicity study of a haloalkene degradant of sevoflurane, compound A (PIFE), in Sprague-Dawley rats Anesthesiology 83 1995 1220-1232
28. Kharasch ED Jubert C Compound A uptake and metabolism to mercapturic acids and 3,3-trifluoro-2-fluoromethoxypropanoic acid during low flow sevoflurane anesthesia Anesthesiology 91 1999 1267-1278
29. Jin L Baillie TA Davis MR et al. Nephrotoxicity of sevoflurane compound A in rats: evidence for glutathione and cysteine conjugate formation and the role of renal cysteine conjugate β-lyase Biochemical and Biophysical Research Communications 210 1995 498-506
30. Ramaswamy AI Anders MW Cysteine conjugate β-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product compound A in human, nonhuman primate, and rat kidney cytosol and mitochondria Anesthesiology 85 1996 454-461
31. Martin JL Laster MJ Kandel L et al. Metabolism of compound A by renal cysteine-S-conjugate beta-lyase is not the mechanism of compound A-induced renal injury in the rat Anesthesia and Analgesia 82 1996 770-774
32. Eger EI Gong D Koblin DD et al. Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers Anesthesia and Analgesia 85 1997 1154-1163
33. Eger EI Gong D Koblin DD et al. The effect of anesthetic duration on kinetic and recovery characteristics of desflurane versus sevoflurane, and on the kinetic characteristics of compound A in volunteers Anesthesia and Analgesia 86 1998 414-421
34. Goldberg ME Cantillo J Gratz I et al. Dose of compound A, not sevoflurane, determines changes in the biochemical markers of renal injury in healthy volunteers Anesthesia and Analgesia 88 1999 437-445
35. Mazze RI Jamison RL Low-flow (1 l/min) sevoflurane - Is it safe? Anesthesiology 86 1997 1225-1227
36. Bito H Ikeuchi Y Ikeda K Effects of low-flow sevoflurane anesthesia on renal function. comparison with high-flow sevoflurane and low-flow isoflurane anesthesia Anesthesiology 86 1997 1231-1237
37. Kharash E D Frink E J Zager R et al. Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity Anesthesiology 86 1997 1238-1253
38. Goeters Ch Reinhardt C Gronau E et al Minimal flow sevoflurane and Isoflurane anaesthesia and impact on renal function European Journal of Anaesthesiology 18 2001 43-50
39. Ruzicka JA Hidalgo JC Tinker JH et al Inhibition of volatile sevoflurane degradation product formation in an anesthetic circuit by a reduction in soda lime temperature Anesthesiology 81 1994 238-244
40. Cunnigham DD Huang S Webster J et al. Sevoflurane degradation to compound A in anaesthesia breathing systems British Journal of Anaesthesia 77 1996 537-543
41. Wissing H Kuhn I Kessler P Das Wärme-Feuchte-Profil des Physioflex. Untersuchungen am Modell Anaesthesist 46 1997 201-206
42. Funk W Gruber M Jakob W et al. Compound A does not accumulate during closed circuit sevoflurane anaesthesia with the Physioflex British Journal of Anaesthesia 83 1999 571-575
43. Mazze RI Friedman M Delgado-Herrera L et al. Renal toxicity of compound A plus sevoflurane compared with isoflurane in non-human primates Anesthesiology 89 1998 A490
44. Kharasch ED Putting the brakes on anesthetic breakdown Anesthesiology 91 1999 1192-1194
45. Obata R Bito H Ohmura M et al. The effects of low-flow sevoflurane anesthesia on renal and hepatic function Anesthesia and Analgesia 91 2000 1262-1268
46. Ebert TJ Arain SR Renal responses to low-flow desflurane, sevoflurane, and propofol in patients Anesthesiology 93 2000 1401-1406
47. Conzen PF Kharasch ED Czerner SFA et al. Low-flow sevoflurane compared to low-flow isoflurane anesthesia in patients with stable renal insufficiency Anesthesiology 97 2002 578-584
48. Neumann MA Laster MJ Weiskopf RB et al. The elimination of sodium and potassium hydroxides from desiccated soda lime diminishes degradation of desflurane to carbon monoxide and sevoflurane to compound A but does not compromise carbon dioxide absorption Anesthesia and Analgesia 89 1999 768-773
49. Baxter PJ Garton K Kharasch ED Mechanistic aspects of carbon monoxide formation from volatile anesthetics Anesthesiology 89 1998 929-941
50. Förster H Das Soda lime - Problem Anaesthesist 48 1999 409-416
51. Yamakage M Yamada S Chen X et al. Carbon dioxide absorbents containing potassium hydroxide produce much larger concentration of compound A from sevoflurane in clinical practice Anesthesia and Analgesia 91 2000 220-224
52. Stabernack CR Brown R Laster MJ et al. Absorbents differ enormously in their capacity to produce compound A and carbon monoxide Anesthesia and Analgesia 90 2000 1428-1435
53. Higuchi H Adachi Y Arimura S et al. The carbon dioxide absorption capacity of Amsorb is half that of soda lime Anesthesia and Analgesia 93 2001 221-225
54. Versichelen L Bouche MP Rolly G et al. Only carbon dioxide absorbents free of both NaOH and KOH do not generate compound A during in vitro closed-sytem sevoflurane evaluation of five absorbents Anesthesiology 95 2001 750-755
55. Bito H Personal communication
56. Murray J M Renfrew C W Bedi A et al. Amsorb: a new carbon dioxide absorbent for use in anaesthetic breathing systems Anesthesiology 91 1999 1342-1348
57. Higuchi H Adachi Y Arimura S et al. Compound A concentration during low-flow sevoflurane anesthesia correlate directly with the concentration of monovalent bases in carbon dioxide absorbents Anesthesia and Analgesia 91 2000 434-439
58. Warnken U H Förster H Transhalogenation of sevoflurane catalysed by dry Amsorb Anesthesiology 95 2001 A1140
59. Baum JA Low-flow anesthesia: theory, practice, technical preconditions, advantages, and foreign gas accumulation Journal of Anesthesiology 13 1999 166-174
60. Baum J Sievert B Stanke HG et al. Lachgasfreie Niedigfluβnarkosen Anaesthesiologie und Reanimation 25 2000 60-67
61. Baum J Enzenauer J Krausse Th et al. Atemkalk, Nutzungsdauer, Verbrauch und Kosten in Abhängigkeit vom Frischgasfluβ Anaesthesiologie und Reanimation 18 1993 108-113
62. Baum J van Aken H Calcium hydroxide lime - a new carbon dioxide absorbent: a rationale for judicious use of different absorbents European Journal of Anaesthesiology 17 2000 597-600
63. Ueyama H Takashina M Suzuki T et al. Warning: carbon dioxide absorption capacity was unexpectedly low in low-flow anesthesia Anesthesiology 93 2000 1560-1561
64. Adriani J The chemical absorption of carbon dioxide in rebreathing appliances In Adriani J (ed.), The Chemistry of Anaesthesia 1946 69-100 Blackwell Scientific Publications Oxford
65. Förster H Behne M Warnken UH et al. Die Anwendung von Lithiumhydroxid als Kohlendioxidabsorbens verhindert das Entstehen von Compound A während Sevoflurananästhesie Anaesthesist 49 2000 106-112
66. Holloway AM Possible alternatives to soda lime Anaesthesia and Intensive Care 24 1994 359-362
67. Perhag L Reinstrup P Thomasson R The Reflector: a new method for saving anaesthetic vapours British Journal of Anaesthesia 85 2000 482-486
68. Enlund M Lambert H Wiklund L The sevoflurane saving capacity of a new anaesthetic agent conserving device compared with low flow circle system Acta Anaesthesiologica Scandinavica 46 2002 506-511